Skip to main content
Account

Peer review reports

From: Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada

Original Submission
18 Jan 2019 Submitted Original manuscript
8 Feb 2019 Reviewed Reviewer Report - Douglas Ball
11 Feb 2019 Reviewed Reviewer Report - Luisa Agnello
12 Mar 2019 Author responded Author comments - Maria Luisa Aznar
Resubmission - Version 2
12 Mar 2019 Submitted Manuscript version 2
18 Mar 2019 Author responded Author comments - Maria Luisa Aznar
Resubmission - Version 3
18 Mar 2019 Submitted Manuscript version 3
22 Mar 2019 Author responded Author comments - Maria Luisa Aznar
Resubmission - Version 4
22 Mar 2019 Submitted Manuscript version 4
15 Apr 2019 Author responded Author comments - Maria Luisa Aznar
Resubmission - Version 5
15 Apr 2019 Submitted Manuscript version 5
Publishing
17 Apr 2019 Editorially accepted
3 Jun 2019 Article published 10.1186/s40360-019-0302-1

Learn about peer review

Back to article page

Navigation